If the country is serious about ending the opioid epidemic, an excellent place to start is by removing restrictions on methadone that create opportunity costs for people needing help and stigmatize…
In the latest edition of STAT Health Tech: Elizabeth Holmes found guilty of fraud, new FDA signposts for tech in clinical trials, and digital therapeutics at CES.
‘Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states.” That was just one of the observations in a new report on how…
Texas is trying to create the nation’s next biotech hub, and it’s doing so with a dose of Texas-sized ambition.
Rep. Beth Liston, a state lawmaker in Ohio, supports Covid-19 vaccines. But polarized politics led her to refuse campaign contributions from the pharmaceutical companies that make them.
New York-based Applied Therapeutics deployed heavy-handed legal tactics to scare short sellers into silence.
‘She was convicted on the big counts,’ said Erik Gordon, a business and law professor at the University of Michigan. ‘The big counts were the fraud committed against investors, not the counts…
As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a median of 4.9% on more than 450 prescription medicines.
Peter Marks helms the FDA’s Center for Biologics Evaluation and Research, which handled all of the Covid-19 vaccine reviews. He’s hoping 2022 is the year CBER can get back to normal.
Scientists and innovators must learn from the Theranos debacle so people truly benefit from new blood-testing technologies and approaches and the quality care they unlock.
